Dutch agency advises against insuring Wegovy
Danish drugmaker Novo Nordisk was disappointed that the Dutch government was advised not to cover its hugely popular weight-loss drug Wegovy in the country’s basic insurance. The Netherlands Institute for Health Care said it was unclear whether the health effects of Wegovy were significant enough to offset the costs of the drug.
BELIEBTE BEITRÄGE
Putin may discuss Ukraine peace deal with Trump
November 22, 2024
Spain’s vice-president Ribera blames floods on climate change
November 22, 2024
Storm lashes northwestern US, killing two people
November 22, 2024
Iceland volcano erupts for tenth time in three years
November 22, 2024
LIVEÜBERTRAGUNG